Literature DB >> 32081630

Comparative reactivity analysis of small-molecule thiol surrogates.

László Petri1, Péter Ábrányi-Balogh1, Petra Regina Varga1, Tímea Imre2, György Miklós Keserű3.   

Abstract

Targeted covalent inhibitors represent an increasingly popular approach to modulate challenging drug targets. Since covalent and non-covalent interactions are both contributing to the affinity of these compounds, evaluation of their reactivity is a key-step to find feasible warheads. There are well-established HPLC- and NMR-based kinetic assays to tackle this task, however, they use a variety of cysteine-surrogates including cysteamine, cysteine or acetyl-cysteine and GSH. The diverse nature of the thiol sources often makes the results incomparable that prevents compiling a comprehensive knowledge base for the design of covalent inhibitors. To evaluate kinetic measurements from different sources we performed a comparative analysis of the different thiol surrogates against a designed set of electrophilic fragments equipped with a range of warheads. Our study included seven different thiol models and 13 warheads resulting in a reactivity matrix analysed thoroughly. We found that the reactivity profile might be significantly different for various thiol models. Comparing the different warheads, we concluded that - in addition to its human relevance - glutathione (GSH) provided the best estimate of reactivity with highest number of true positives identified.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Covalent fragments; Cysteamine; Cysteine; Cysteine reactivity; Glutathione; Reactivity assay; Thiol surrogate; Warhead

Mesh:

Substances:

Year:  2020        PMID: 32081630     DOI: 10.1016/j.bmc.2020.115357

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

Review 1.  Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module.

Authors:  Thomas J Schmidt; Karl-Heinz Klempnauer
Journal:  Molecules       Date:  2022-03-23       Impact factor: 4.411

2.  Rational design, optimization, and biological evaluation of novel α-Phosphonopropionic acids as covalent inhibitors of Rab geranylgeranyl transferase.

Authors:  Joanna Małolepsza; Aleksandra Marchwicka; Remigiusz A Serwa; Sanna P Niinivehmas; Olli T Pentikäinen; Edyta Gendaszewska-Darmach; Katarzyna M Błażewska
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

3.  Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core.

Authors:  Ravi Tripathi; Abiodun Anifowose; Wen Lu; Xiaoxiao Yang; Binghe Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

4.  Covalent inhibitor reactivity prediction by the electrophilicity index-in and out of scope.

Authors:  Markus R Hermann; Alexander Pautsch; Marc A Grundl; Alexander Weber; Christofer S Tautermann
Journal:  J Comput Aided Mol Des       Date:  2020-10-05       Impact factor: 3.686

5.  Synthesis of Guaianolide Analogues with a Tunable α-Methylene-γ-lactam Electrophile and Correlating Bioactivity with Thiol Reactivity.

Authors:  Paul A Jackson; Henry A M Schares; Katherine F M Jones; John C Widen; Daniel P Dempe; Francois Grillet; Matthew E Cuellar; Michael A Walters; Daniel A Harki; Kay M Brummond
Journal:  J Med Chem       Date:  2020-11-17       Impact factor: 7.446

6.  In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease.

Authors:  Muya Xiong; Tianqing Nie; Qiang Shao; Minjun Li; Haixia Su; Yechun Xu
Journal:  Eur J Med Chem       Date:  2022-01-23       Impact factor: 6.514

7.  Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads.

Authors:  Levente Kollár; Martina Gobec; Matic Proj; Lara Smrdel; Damijan Knez; Tímea Imre; Ágnes Gömöry; László Petri; Péter Ábrányi-Balogh; Dorottya Csányi; György G Ferenczy; Stanislav Gobec; Izidor Sosič; György M Keserű
Journal:  Cells       Date:  2021-12-06       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.